IR Information
Notice of Formulation of Management Plan “Mission 2030” Phase 2 (FY2026–FY2028)
Presentation Material for Management Presentation on Feb 27th 2026
Notice of Commencement of Consideration of Spin-off of Styrene-Related Businesses
FY2025 Third Quarter Financial Results Presentation Summary of Q&A Session
FY2025 Third Quarter Financial Results Presentation Materials with Script
Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)
Notice Regarding Recognition of Extraordinary Losses
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.